Dysmenorrhö und Leistungssport

In: Frau im Leistungssport · 1988 · pp. 107–117 · doi:10.1007/978-3-642-73509-7_9 · W18364453
book-chapter OA: closed CC0
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-07+body, 2026-07-14

This paper discusses dysmenorrhea, its prevalence, intensity, objective measurements, and the distinction between primary and secondary forms, noting associated organic causes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-14 · read from full text

The chapter discusses cramp-like pain during menstruation (dysmenorrhea), reporting literature estimates that it affects about 15–72% of young women and girls, with ovulatory cycles; pain is described as strongest on the first day of bleeding and often therapy-requiring. As an objective correlate to subjective pain, it summarizes measurements showing a different intrauterine pressure course in dysmenorrhea compared with eumenorrhea, including longer-lasting pressure increases. It distinguishes primary dysmenorrhea (treated as symptomatic) from secondary dysmenorrhea linked to organic pathology, naming retroflexion of the uterus, endometriosis, uterine fibroids, and adhesions, while noting that congenital uterine malformations and cervical stenosis are mentioned relatively often but are extremely rare, which the authors explicitly caution about. Relevance to endometriosis: endometriosis is explicitly named among the organic causes of secondary dysmenorrhea in this chapter, though the paper mainly provides a general overview of dysmenorrhea and its classification in the context of performance sport.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 5,214 characters · extracted from oa-doi-fallback · click to expand
Zusammenfassung Die folgenden Ausführungen beschäftigen sich mit krampfartigen Schmerzzuständen während der Menstruation, die je nach Literaturangaben bei 15–72% aller jüngeren Frauen und Mädchen vorkommen (Übersicht bei Andersch u. Milsom 1982).Weiterhin ist der Zyklus dieser Frauen ovulatorisch. Die Schmerzintensität ist jeweils am ersten Blutungstag am stärksten und dabei zumeist therapiebedürftig. Als objektivierender Befund der subjektiv geäußerten Schmerzempfindung wird im Vergleich zur Eumenorrhö ein unterschiedlicher intrauteriner Druckverlauf mit länger anhaltenden Druckerhöhungen gemessen (Lumsden u. Baird 1985). Man unterscheidet zwischen einer primären und einer sekundären Dysmenorrhö. Die primäre Dysmenorrhö gilt als symptomatische Form dieses Beschwerdebildes. Die sekundäre Dysmenorrhö wird mit pathologischen organischen Veränderungen in Verbindung gebracht. Retroflexio uteri, Endometriose, Uterus myomatosus oder Verwachsungen werden genannt. Relativ häufig erwähnt, obwohl in Wirklichkeit extrem selten vorkommend, werden auch uterine Mißbildungen oder Zervixstenosen (Gitsch u. Janisch 1984; Käser et al. 1972; Kepp-Staemmler 1982; Knörr et al. 1982; Schmidt-Mathiesen 1985; Stegner 1979). Preview Unable to display preview. Download preview PDF. Similar content being viewed by others Literatur Andersch B, Milsom I (1982) An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol 144: 665–672 Comparato MR (1985) Feldene en el tratamiento de la dismenorrea primaria. Estudio multicentrico. Obstet Ginecol LatAm 43:117–124 Csapo AI, Pulkkinen MO, Henzl MR (1977) The effect of naproxen-sodium on the intrauterine pressure and menstrual pain of dysmenorrhea patients. Prostaglandins 13:193–198 Gitsch E, Janisch H (1984) Gynäkologie. Maudrich, Wien München Bern Käser O, Friedberg V, Ober KG, Thomsen K, Zander J (1972) Gynäkologie und Geburtshilfe - Spezielle Gynäkologie III. Thieme, Stuttgart New York Kaiser R, Pfleiderer A (1985) Lehrbuch der Gynäkologie. Thieme, Stuttgart New York Kauppila A, Rönnberg L (1985) Naproxen-sodium in dysmenorrhea secondary to endometriosis. Obstet Gynecol 65: 379–383 Knörr K, Knörr-Gärtner H, Beller FK, Lauritzen C (1982) Lehrbuch der Geburtshilfe und Gynäkologie. Springer, Berlin Heidelberg New York Lumsden MA, Baird DT (1985) Intra uterine pressure in dysmenorrhea. Acta Obstet Gynecol Scand 64:183–186 Pashby NL, Mansel RE, Preece PE, Hughes LE, Aspinall J (1981) A clinical trial of evening primrose oil (efamol) in mastalgia. British Surgical Research Society, Cardiff Meeting Pickles VR (1957) A plain-muscle stimulant in the menstruum. Nature 180:1198 Pickles VR, Hall WJ, Best FA, Smith GN (1965) Prostaglandins in endometrium and menstrual fluid from normal and dysmenorrhoeic subjects. J Obstet Gynecol Br Commonw 72:185–192 Quaas L, Zahradnik HP (1985)The effect of alpha-and beta-adrenergic stimulation on contractility and prostaglandin (PGE2 and F2α and 6-keto-PGF1α) production of pregnant human myometrial strips. Am J Obstet Gynecol 152: 852–856 Quaas L, Zahradnik HP, Hillemanns HG (1985) Die Wirkung von Magnesium auf die Kontraktionsaktivität menschlicher Myometriumsstreifen und deren Prostaglandin- freisetzung. In: Weidinger H (Hrsg) Magnesium und Schwangerschaft. Beltz, Weinheim Basel Quaas L, Göppinger A, Zahradnik HP (im Druck) The effect of acetylsalicylic acid and indomethacin on the catecholamin- and oxytocine-induced contractility and prostaglandin (6-keto-PGFi1α, PGF2α)-production of human pregnant myometrial strips. Prostaglandins 34 Schmidt-Mathiesen H (1985) Gynäkologie und Geburtshilfe. Schattauer, Stuttgart New York Stegner HE (1979) Gynäkologie und Geburtshilfe, 3. Aufl. Enke, Stuttgart Ulmsten U (1985) Calcium blockade as a rapid pharmacological test to evaluate primary dysmenorrhea. Gynecol Obstet Invest 20: 78–83 Wilhelmsson L, Jonsson K, Hailing L, Hermann M, Lindell J, Nilsson B (1985) Piroxicam in the treatment of primary dysmenorrhea. Acta Obstet Gynecol Scand 64: 317–321 Zahradnik HP, Breckwoldt M (1984) Contribution to the pathogenesis of dysmenorrhea. Arch Gynecol 236: 99–108 Zahradnik HP, Stengele E, Kraut E, Scharpf G, Breckwoldt M (1978a) Neue Aspekte zur Pathogenese und Therapie der Dysmenorrhoe. Prostaglandin-F2α-spiegel im Menstrualblut. Dtsch MedWochenschr 103:1270–1273 Zahradnik HP, Stengele E, Kraut E, Breckwoldt M (1978b) Neue Aspekte zur Pathogenese und Therapie der Dysmenorrhoe. Progesteronspiegel im Menstrualblut. Dtsch MedWochenschr 103:1298–1301 Zahradnik HP, Neulen J, Breckwoldt M (im Druck) Eicosanoide und Menstruation. Arch Gynecol [Suppl] 97 Editor information Editors and Affiliations Rights and permissions Copyright information © 1988 Springer Verlag Berlin Heidelberg About this chapter Cite this chapter Zahradnik, H.P., Neulen, J., Quaas, L. (1988). Dysmenorrhö und Leistungssport. In: Wurster, K.G., Keller, E. (eds) Frau im Leistungssport. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73509-7_9 Download citation DOI: https://doi.org/10.1007/978-3-642-73509-7_9 Publisher Name: Springer, Berlin, Heidelberg Print ISBN: 978-3-540-19055-4 Online ISBN: 978-3-642-73509-7 eBook Packages: Springer Book Archive

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (18)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-08-09T06:42:26.407065+00:00
License: CC0 · commercial use OK